[ARWR] YoY Annual Result on 30-Sep-2013 [#FY]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
18-Dec-2013
Financial Year
2013
Quarter
30-Sep-2013 [#FY]
Profit Trend
YoY- -47.42%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Annual Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 158 382 175 290 147 296 620 -20.35%
PBT -81,721 -91,938 -58,720 -31,703 -22,111 -8,785 -7,336 49.38%
Tax 2 2 5 6,223 -203 -6,865 -3,248 -
NP -81,723 -91,941 -58,630 -31,143 -21,126 -3,129 -5,774 55.46%
Tax Rate - - - - - - - -
Total Cost 81,881 92,323 58,805 31,434 21,273 3,425 6,394 52.89%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -51,614.64 -24,068.29 -33,502.97 -10,729.22 -14,383.61 -1,056.56 -931.15 95.14%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -1.34 -1.60 -1.25 -1.30 -1.90 -0.44 -0.90 6.85%
EPS Diluted -1.34 -1.60 -1.25 -1.30 -1.90 -0.44 -0.90 6.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.